Evidence map›Paper›PMID 32231056›Full record

ArticleJournal of clinical medicine2020

Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.

Sven Schneider, Nicholas J Campion, Sergio Villazala-Merino, David Tianxiang Liu, Tina Bartosik, Lukas D Landegger, Navid Ahmadi, Christian A Mueller, Erich Vyskocil, Victoria Stanek and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Trial
  3. [Progress and prospects of anti-IL-4/IL-13 monoclonal antibody treatment in chronic rhinosinusitis with nasal polyps].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Review
  4. Development and validation of a clinical risk prediction model for chronic sinusitis with nasal polyps: a retrospective analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  5. Article
  6. Article
  7. Correlation of sino-nasal outcome test and nasal polyp score in dupilumab-treated chronic rhinosinusitis with nasal polyps.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE.The journal of allergy and clinical immunology. Global · 2024
    Article
  12. Efficacy of Biologics in NSAID-ERD: United Airways From the Nose to the Bronchi.The journal of allergy and clinical immunology. In practice · 2024
    Review
  13. Article
  14. Article
  15. The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Article
  16. Sensibility, specificity, and accuracy of the Sinonasal Outcome Test 8 (SNOT-8) in patients with chronic rhinosinusitis (CRS): a cross-sectional cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Sven SchneiderDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7631-3746
Nicholas J CampionDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
Sergio Villazala-MerinoDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
David Tianxiang LiuDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6948-737X
Tina BartosikDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
Lukas D LandeggerDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9660-2625
Navid AhmadiDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-3246-5905
Christian A MuellerDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
Erich VyskocilDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
Victoria StanekDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.
Tamara QuintDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.
Christine BangertDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.
Julia Eckl-DornaDepartment of Otorhinolaryngology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5981-1607
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic rhinosinusitis (CRS) is a common disease that substantially impairs the quality of life (QoL). Here, we aimed to assess patients' QoL in different subtypes of CRS and correlated this with nasal polyp size to improve the clinical understanding of the burden of disease. In this retrospective single-center study, 107 patients with the following diagnoses were analyzed: CRS without nasal polyps (CRSsNP), CRS with nasal polyps (CRSwNP), or aspirin-exacerbated respiratory disease (AERD). Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV) scores and their correlation with endoscopic Total Polyp Scores (TPS) were evaluated. The mean SNOT-20 GAV scores were highest in patients with AERD (AERD = 43.4, CRSwNP = 36.3, CRSsNP = 30.9). A statistically significant correlation of total SNOT-20 GAV score with TPS was observed in CRSwNP patients (r = 0.3398,

Indexed as

aspirin-exacerbated respiratory diseasechronic rhinosinusitisnasal polypsSino-Nasal Outcome Test-20 German Adapted Version

Identifiers

PMID32231056
PMCPMC7230739
OpenAlexW3013351791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.